A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Condition:   Liver Cirrhosis Interventions:   Drug: Human albumin;   Drug: Enoxaparin;   Drug: Standard medical treatment Sponsor:   European Foundation for Study of Chronic Liver Failure Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials